UNSPSC 51342101: Enviradene

This classification denotes an antiviral agent with the molecular formula C19H21N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Q79A81839, chemically known as 1h-benzimidazol-2-amine, 1-((1-methylethyl)sulfonyl)-6-(1-phenyl-1-propenyl)-, (e)- but generally known as enviradene, which bears US NIH Compound Identifier 6435398. European Medicines Agency schedules Enviradene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06555MIG. The term ENVIRADENE is an International Non-Proprietary Name.

UNSPSC 51342101 Enviradene (Commodity) covers naloxone, drug deactivation systems, and related pharmaceutical and medical supplies procured by state and local health authorities, emergency services, and cooperative purchasing alliances to support public health initiatives, emergency response, and pharmacy benefit programs. State and local governments buy these products through competitive sealed bidding (IFB), requests for proposal (RFP), and requests for information (RFI) when establishing supply agreements with manufacturers, wholesalers, or direct-contract vendors. Issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance / MMCAP). The mix reflects both direct procurement by individual jurisdictions and aggregated purchasing through cooperative vehicles that serve multiple state and local members.

Recent activity spans Florida, Texas, and the Upper Midwest through MMCAP's multi-state footprint. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023 (the bid record appears to contain a date discrepancy). The City of Tampa issued ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered small local business enterprise set-aside with a 5 percent bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capability information on direct-to-manufacturer prescription fulfillment programs. MMCAP, administered by Minnesota's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026, and contract effectiveness July 1, 2026. Vendors responding to these opportunities must demonstrate FDA compliance, cGMP certification, proper insurance coverage, and capacity to meet distribution timelines through authorized wholesalers or direct delivery.